Buflomedil (HCl)

Buflomedil (HCl) is a vasodilator (relaxes the blood vessels). Buflomedil (HCl) is used in the treatment of cerebro-vascular and peripheral vascular diseases.


Adult Dose
Dose: 50 mg
Single Dose: 50 (50)
Frequency: 12 hourly
Route: IM
Instructions: For 14-Days
Neonatal
Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group
Paedriatic
Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group
Characteristics
. It is of Synthetic origin and belongs to Pyrolidine. It belongs to Platelet Aggregation Inhibitor pharmacological group on the basis of mechanism of action and also classified in Vasodilators pharmacological group.The Molecular Weight of Buflomedil (HCl) is 343.80.
Contraindications
Buflomedil (HCl) is contraindicated in conditions like Arterial hemorrhage.
Effects
The signs and symptoms that are produced after the acute overdosage of Buflomedil (HCl) include Hypotension, Tachycardia, Convulsions.The symptomatic adverse reactions produced by Buflomedil (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, VertigoX, GI disturbance, Vasodilation.
Indications
'Buflomedil (HCl) is primarily indicated in conditions like Dementia, Disorientation, Insomnia, Intermittant claudication, Ischaemic rest pain, Loss of concentration, Loss of memory, Raynaud''s syndrome, Skin ulceration, Tinnitus, Trophic disorders, Vertigo.'
Interactions
No data regarding the interactions of Buflomedil (HCl) was found.
Interfrence
Risks
Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Tabs Store in a well closed container, . Protect from Sunlight, Moisture and Heat.
Warnings
Buflomedil (betablocker) should not be given to patients with bronchospasm, asthma, with history of obstructive airway disease, metabolic acidosis, partial heart block, sinus bradycardia or psoriasis. The dose may need to reduce in patients with renal (kidney) or hepatic (liver) dysfunction. Patients with long term treatment with betablockers should have their medication discontinued gradually over a period of 1 to 2 weeks, because it may result in angina, myocardial infraction (MI), ventricular arrhythmia or death. This drug should be used only if clearly needed during pregnancy or lactation.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.